Security key
092667104
Strata Critical Medical, Inc. - Common Stock (SRTA)
CUSIP: 092667104
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 52,008,878
- Total 13F value
- $250,146,841
- Share change
- +2,186,826
- Put/Call ratio
- 13%
- SEC-reported price per share
- $4.81
- Number of holders
- 126
- Value change
- +$9,910,903
- Number of buys
- 56
- Number of sells
- 63
- Shares outstanding
- 86,419,462
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
126
Top holders
10
SRTA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Strata Critical Medical, Inc. SEC filings
Strata Critical Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 092667104
Recent filing periods:
Ownership snapshot
Top reported holders of SRTA - Strata Critical Medical, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Third Point LLC
Disclosed value leader
ARK Investment Management...
Comparable rows
15/15
Latest evidence
05 Dec 2025
13D/G
13F
3/4/5
Lead comparable stake: 5.8%
13D/G row: Third Point LLC
Showing 1-6 of 15 holder rows.
Quick read
Third Point LLC leads the comparable SEC ownership view at 5.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Third Point LLC's linked filing trail.
Comparable ownership
Top 5
Third Point LLC
5.8%
BlackRock, Inc.
5.1%
Robert S. Wiesenthal
6.1%
Louis R. Verdetto
1.5%
Eric L. Affeldt
0.67%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Third Point LLC |
13D/G
13F
Company
|
5.8%
|
$25,300,000
5,000,000 shares
|
$0 | 30 Sep 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.1%
from 13D/G
|
$21,858,385
4,319,887 shares
mixed-class rows
|
— | 30 Sep 2025 |
| Robert S. Wiesenthal |
3/4/5
Director
|
6.1%
|
$23,371,182
5,275,662 shares
|
— | 29 Aug 2025 |
| Louis R. Verdetto |
3/4/5
CEO Keystone Perfusion Service
|
1.5%
|
$6,456,727
1,266,025 shares
|
— | 02 Dec 2025 |
| Eric L. Affeldt |
3/4/5
Director
|
0.67%
|
$2,353,916
581,214 shares
|
— | 01 Aug 2025 |
| Edward M. Philip |
3/4/5
Director
|
0.27%
|
$948,368
234,165 shares
|
— | 01 Aug 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
126
Shares
52,008,878
Rows available
126
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
136
Q4 2025 holders
126
Holder diff
-10
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend